-
120285
DN
dominant negative
927
-
120275
DN
double-negative
822
-
120288
DN
de novo
31
-
120240
DN
daunorubicin
9
-
120291
dn
deafness
8
-
120273
DN
dose-normalized
7
-
120274
DN
double null
4
-
120290
dn
deafness locus
3
-
120279
DN
denatured
3
-
120272
dn
double knockout
3
-
120250
dn
different
2
-
120287
dn
TAT-dominant-negative
2
-
120295
dn
daily urine volume of GIPR
1
-
120289
dn
day-night average sound level L
1
-
120293
dn
decreased in 5-month-old GIPR
1
-
120292
dn
denaturational temperature T(h)
1
-
120278
dn
dependence of the necrosis depth
1
-
120286
dn
DESIGN AND METHODS: GIPR
1
-
120281
dn
deteriorated in GIPR
1
-
120280
dn
diabetes-associated kidney lesions in GIPR
1
-
120283
dn
diabetic phenotype of GIPR
1
-
120282
dn
diameter of the nanowire
1
-
120284
dn
disturbances in diabetic GIPR
1
-
120269
dn
dominant-negative mutant
1
-
120271
dn
dominant-negative unc-1 transgenes. unc-1
1
-
120270
dn
dose xn
1
-
120277
dn
high-dose transgenic let-60
1
-
120276
dn
nervous disorder
1
-
120294
dn
Suv4-20h-double-null
1